EP2379057 - Bibliographic data
PHENYLEPHRINE FORMULATIONS WITH IMPROVED STABILITY
| Last update | 13/07/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Euro-PCT |
| (73) Holder |
NOVARTIS AG Lichtstrasse 35
4056 Basel
Suisse
|
|---|---|
| (72) Inventors |
DUNGAN, Timothy Novartis Consumer Health 10401 Highway 6
Lincoln, Nebraska 68517
États-Unis d'Amérique
WARRINGTON, Brian Novartis Consumer Health 10401 Highway 6
Lincoln, Nebraska 68517
États-Unis d'Amérique
|
| (74) Agent |
Mail recipient LIPHARDT, BERND Novartis Consumer Health SA OTC Patent and Trademark Group Werk Rosental
4002 Basel
Suisse
|
| (21) Request number | EP09795623.9 |
|---|---|
| (22) Request date | 11/12/2009 |
| (11) Publication number | EP2379057 |
|---|---|
| Publication date | 17/07/2013 |
| (54) Title of the invention | PHENYLEPHRINE FORMULATIONS WITH IMPROVED STABILITY |
|---|---|
| (51) International classification | A61K 9/20, A61K 31/167, A61K 31/137, A61K 31/135, A61K 31/485, A61K 31/375 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 139391 P |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 5 -
Amount: 55 € -
Due date 02/01/2014
Surtax: 5 - Amount: 11 € - Due date 03/07/2014 |
|---|---|
| Last annuity | None |
| Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2013/3, of 30/09/2013 |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 17/07/2013 Entrée en période de grâce du brevet d'invention - Legal date 03/01/2014 Déchéance du brevet d'invention après période de grâce - Legal date 02/01/2014 |